WHAT IS THE BEST PLASMATIC ACTIVITY WHICH COULD BE CORRELATED WITH THE ANTITHROMBOTIC EFFECT OF HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT

被引：13

作者：

DOUTREMEPUICH, C ^{[1
]}

CASTRIOTO, T ^{[1
]}

DESEZE, O ^{[1
]}

PEREIRA, F ^{[1
]}

DOUTREMEPUICH, F ^{[1
]}

ANNE, MC ^{[1
]}

TOULEMONDE, F ^{[1
]}

机构：

[1] INST CHOAY,F-75016 PARIS,FRANCE

来源：

THROMBOSIS RESEARCH | 1987年 / 48卷 / 02期

关键词：

D O I：

10.1016/0049-3848(87)90421-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：245 / 251

页数：7

共 13 条

[1] LACK OF CORRELATION BETWEEN INVITRO AND INVIVO ANTITHROMBOTIC ACTIVITY OF HEPARIN FRACTIONS AND RELATED-COMPOUNDS - HEPARAN-SULFATE AS AN ANTITHROMBOTIC AGENT INVIVO [J].

BIANCHINI, P ;

OSIMA, B ;

PARMA, B ;

NADER, HB ;

DIETRICH, CP .

THROMBOSIS RESEARCH, 1985, 40 (05) :597-607

[2] EFFECTS OF HEPARIN, ITS LOW-MOLECULAR WEIGHT FRACTIONS AND OTHER GLYCOSAMINOGLYCANS ON THROMBUS GROWTH-INVIVO [J].

BONEU, B ;

BUCHANAN, MR ;

CADE, JF ;

VANRYN, J ;

FERNANDEZ, FF ;

OFOSU, FA ;

HIRSH, J .

THROMBOSIS RESEARCH, 1985, 40 (01) :81-89

[3]

BRATT G, 1985, THROMB HAEMOSTASIS, V54, P813

[4] ARE MOLECULAR-WEIGHT AND ANTI-XA ACTIVITY SUFFICIENT TO PREDICT THE ANTITHROMBOTIC POWER OF HEPARIN FRACTIONS [J].

DOUTREMEPUICH, C ;

BOUSQUET, F ;

TOULEMONDE, F .

THROMBOSIS RESEARCH, 1986, 44 (05) :709-712

[5]

DOUTREMEPUICH C, 1985, ANN PHARM FR, V43, P161

[6]

DOUTREMEPUICH C, 1983, HAEMOSTASIS, V13, P109

[7]

FANTUZ M, 1986, ARCH INT PHARMACOD T, V282, P328

[8] A SENSITIVE MODEL OF VENOUS THROMBOSIS IN RATS [J].

HLADOVEC, J .

THROMBOSIS RESEARCH, 1986, 43 (05) :539-544

[9]

JANVIER G, 1987, HAEMOSTASIS, V7, P49

[10] FAILURE OF ASPIRIN AT DIFFERENT DOSES TO MODIFY EXPERIMENTAL THROMBOSIS IN RATS [J].

REYERS, I ;

MUSSONI, L ;

DONATI, MB ;

DEGAETANO, G .

THROMBOSIS RESEARCH, 1980, 18 (05) :669-674

← 1 2 →